Cancer chemotherapeutics as immunomodulators


Traditionally, cytotoxic chemicals commonly employed in cancer chemotherapy have been looked at essentially under the viewpoint of immunodepression. Thus, the immune activity of these compounds has been regarded not only as a prime factor in the pathogenesis of acute and long-term toxicities associated with cancer chemotherapy (e. g., increased risk of… (More)
DOI: 10.1007/BF01857390


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics